BABA vs HRB

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

HRB presents a dichotomy of deep value and severe technical decay, anchored by a stable Piotroski F-Score of 5/9. While the company exhibits strong valuation metrics with a P/E of 7.16 and a PEG of 0.56, the stock has plummeted 47.5% over the last year. The dividend remains a highlight at 5.48% with a sustainable payout ratio, but significant insider selling by the CEO and a negative Price/Book ratio suggest underlying structural or sentiment risks. The current price of $30.64 is trading almost exactly at its growth-based intrinsic value of $29.96.